PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29382749-2	2018	While the DPP family member DPP4 is extensively characterized in molecular terms as a validated therapeutic target of type II diabetes, experimental 3D structures and ligand-/substrate-binding modes of DPP8 and DPP9 have not been reported.	dipalmitoylphosphatidylserine	10-13	dipeptidyl peptidase 9	Homo sapiens	211-215	
12662155-10	2003	In contrast with the previous results suggesting that DPP9 is inactive, we show that DPP9 is a DPP, hydrolysing Ala-Pro-(7-amino-4-methyl-coumarin) with similar pH-specificity and protease-inhibitor-sensitivity to those of DPP4 and DPP8.	dipalmitoylphosphatidylserine	54-57	dipeptidyl peptidase 9	Homo sapiens	85-89	
21711053-2	2011	The availability of a DPP8-selective compound would be highly instrumental for studying and untwining the biological roles of DPP8 and DPP9 and for the disambiguation of biological effects of nonselective DPP-inhibitors that have mainly been ascribed to blocking of DPPIV"s action.	dipalmitoylphosphatidylserine	22-25	dipeptidyl peptidase 9	Homo sapiens	135-139	
17034148-3	2006	Further modification led to an extremely potent (Ki(DPP)(-)(IV) = 1.0 nM) and selective (Ki(DPP8) > 30 microM; Ki(DPP9) > 30 microM) clinical candidate, ABT-279, that is orally available, efficacious, and remarkably safe in preclinical safety studies.	dipalmitoylphosphatidylserine	52-55	dipeptidyl peptidase 9	Homo sapiens	117-121